Market Tracker

06/29 5:16pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

3.12
Delayed Data
As of Jun 29
 +0.08 / +2.63%
Today’s Change
2.58
Today|||52-Week Range
6.63
-11.86%
Year-to-Date

Today’s Trading

Previous close3.04
Today’s open3.09
Day’s range3.07 - 3.15
Volume1,294,129
Average volume (3 months)1,967,574
Market cap$501.9M
Dividend yield6.41%
Data as of 3:59pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-77.92%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.66%
P/E ratio1.7
Price/Sales0.99
Price/Book0.72

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...-0.07-0.64%
ARRYArray Biopharma Inc+0.06+1.75%
LOXOLoxo Oncology Inc+0.73+3.19%
SGNTSagent Pharmaceutica...+0.12+0.81%
Data as of 4:00pm ET, 06/29/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts